Method administration:
Trenbolone enanthate is administered in injectable form.
Drug Class:
Trenbolone enanthate belongs to the 19-nor family of steroids.
Primary Use:
Trenbolone enanthate is one of the most well known, respected, and popular AAS used in BB’ing today. This is not without good reason, as Trenbolone occupies a very unique place in the steroid world. While most potent mass-building AAS tend to result in significant water retention, Trenbolone breaks the mold by providing the user with the best of both worlds; a steroid which not only causes substantial muscle growth, but also increases hardness, density, vascularity, and dryness at the same time. It is well known as one of the best strength enhancers available, with many strength athletes considering it an indispensable part of their program. As a recomping drug, it doesn’t get any better, as Trenbolone’s proven nutrient repartitioning capabilities have catapulted it to the top of the multi-billion dollar meat industry. In terms of fat loss, again, Trenbolone has no equal, ranking at the very top of the list.
As effective as Trenbolone is from a physical standpoint, its effect on the user’s psyche are just as pronounced. One of the main steroids responsible for coining the term “roid rage”, its ability to increase aggression/assertiveness and the alpha-male mind-set are almost unparalleled, being equaled only by Halotestin. This steroid pairs well with nearly all AAS and can be put to good use in both the off-season and pre-contest. One advantage of Trenbolone enanthate is the typically lower cost per mg compared to the acetate version. While many claim the drug to be unsuitable for beginners, such a broad statement is not always applicable. Still, those individuals contemplating its use should educate themselves beforehand.
substance active | Trenbolone |
---|---|
Amount of substance, mg | 200 |
formulaire de discharge | fiole |
1 bottle, ml | dix |
Packages by package, pcs | 1 |
manufacturer | Bioniche pharmaceutique |
Reviews
There are no reviews yet.